Application interface and display control in an analyte monitoring environment
US-2015205947-A1 · Jul 23, 2015 · US
US12290667B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-12290667-B2 |
| Application number | US-202217806881-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jun 14, 2022 |
| Priority date | Dec 12, 2017 |
| Publication date | May 6, 2025 |
| Grant date | May 6, 2025 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
A monitoring feature, such as, for example, a pen cap, for an insulin delivery device may include at least one circuit adapted to detect at least one of a capping or decapping of the pen cap from an insulin pen and a processor for using information to the at least one of a capping or decapping of the pen cap. A monitoring feature for an insulin delivery device includes at least one circuit adapted to detect use of the insulin delivery device.
Opening claim text (preview).
What is claimed is: 1. An accessory for an insulin pen, the accessory comprising: at least one user interface to display a time since at least one of a capping or decapping of the accessory via one or more indicators; and a controller comprising: at least one processor; and at least one non-transitory computer-readable storage medium storing instructions thereon that, when executed by the at least one processor, cause the controller to: detect at least one of a capping or a decapping of the accessory from an insulin pen; and responsive to the accessory being capped on or uncapped from the insulin pen, determine a missed dose. 2. The accessory of claim 1 , further comprising instructions that, when executed by the at least one processor, cause the controller to: output an alarm based on the missed dose. 3. The accessory of claim 2 , wherein the alarm comprises a missed long-acting dose alarm or a missed rapid-acting dose alarm. 4. The accessory of claim 1 , further comprising instructions that, when executed by the at least one processor, cause the controller to: output a notification based on the missed dose. 5. The accessory of claim 4 , wherein the notification comprises coaching for a user based on the missed dose. 6. The accessory of claim 1 , further comprising an adapter configured to couple the accessory to the insulin pen. 7. The accessory of claim 1 , wherein the accessory comprises a pen cap. 8. The accessory of claim 4 , wherein the notification comprises a time and a dose amount for a correction dose. 9. The accessory of claim 1 , further comprising instructions that, when executed by the at least one processor, cause the controller to: receive glucose data from a glucose monitor. 10. The accessory of claim 9 , further comprising instructions that, when executed by the at least one processor, cause the controller to: automatically display the received glucose data. 11. The accessory of claim 1 , wherein the accessory is configured to be utilized with one or more of a long-acting insulin pen or a rapid-acting insulin pen. 12. The accessory of claim 1 , further comprising instructions that, when executed by the at least one processor, cause the controller to: receive patient-specific therapy parameters from one or more of an application operating on a remote device or manually. 13. The accessory of claim 12 , wherein the patient-specific therapy parameters comprise one or more of dose parameters or timing parameters. 14. The accessory of claim 12 , wherein the patient-specific therapy parameters are received from a healthcare provider device. 15. The accessory of claim 1 , further comprising instructions that, when executed by the at least one processor, cause the controller to: communicate one or more of capping and uncapping data to an application on a remote device. 16. The accessory of claim 1 , further comprising instructions that, when executed by the at least one processor, cause the controller to: communicate one or more of capping and uncapping data to an application on a remote device via a BLUETOOTH communication protocol. 17. The accessory of claim 1 , further comprising instructions that, when executed by the at least one processor, cause the controller to: wirelessly pair the accessory with a remote device. 18. The accessory of claim 1 , further comprising instructions that, when executed by the at least one processor, cause the controller to: responsive to the accessory being capped on or uncapped from the insulin pen for at least a threshold period of time, infer a dosing event. 19. The accessory of claim 1 , further comprising instructions that, when executed by the at least one processor, cause the controller to: responsive to the accessory being capped on or uncapped from the insulin pen for less than a threshold period of time, determine that a dosing event has not occurred. 20. The accessory of claim 1 , further comprising instructions that, when executed by the at least one processor, cause the controller to: receive a manual input indicating a dosing event; and communicate dosing data to a remote device associated with the dosing event. 21. The accessory of claim 1 , further comprising instructions that, when executed by the at least one processor, cause the controller to: cause the one or more indicators to represent a notification that active insulin remains within a user based on a time of a previous capping or decapping of the accessory and a current time. 22. The accessory of claim 21 , further comprising instructions that, when executed by the at least one processor, cause the controller to: determine a time associated with a previous capping or decapping of the accessory; and cause the one or more indicators to disable display of a recommended dose based on a current time and the time associated with the previous capping or decapping of the accessory. 23. A pen cap for an insulin delivery device comprising: at least one user interface comprising at least one indicator for indicating a time since at least one of a capping or decapping of the pen cap; and a controller comprising: at least one processor; and at least one non-transitory computer-readable storage medium storing instructions thereon that, when executed by the at least one processor, cause the pen cap to: detect motion of the pen cap; and responsive to the pen cap being capped on or uncapped from the unsulin delivery device, determine a missed dose. 24. The pen cap of claim 23 , further comprising instructions that, when executed by the at least one processor, cause the controller to: output an alarm based on the missed dose. 25. The pen cap of claim 24 , wherein alarm comprises a missed long-acting dose alarm or a missed raid-acting dose alarm. 26. The pen cap of claim 23 , further comprising instructions that, when executed by the at least one processor, cause the controller to: output a notification based on the missed dose. 27. The pen cap of claim 26 , wherein the notification comprises coaching for a user based on the missed dose. 28. The pen cap of claim 23 , further comprising an adapter configured to couple the pen cap to the insulin delivery device. 29. The pen cap of claim 23 , wherein the pen cap comprises a universal pen cap usable with multiple insulin delivery devices. 30. The pen cap of claim 26 , wherein the notification comprises a time and a dose amount for a correction dose. 31. The pen cap of claim 23 , further comprising instructions that, when executed by the at least one processor, cause the controller to: receive glucose data from a glucose monitor. 32. The pen cap of claim 31 , further comprising instructions that, when executed by the at least one processor, cause the controller to: automatically display the received glucose data. 33. The pen cap of claim 23 , wherein the pen cap is configured to be utilized with one or more of a long-acting insulin pen or a rapid-acting insulin pen. 34. The pen cap of claim 23 , further comprising instructions that, when executed by the at least one processor, cause the controller to: receive patient-specific therapy parameters from one or more of an application operating on a remote device or manually.
Optical measuring means · CPC title
Having specific accessories · CPC title
Kits for diabetics · CPC title
Alarms related to a physiological condition, e.g. details of setting alarm thresholds or avoiding false alarms · CPC title
characterised by tactile indication, e.g. vibration or electrical stimulation · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.